| 14/12/20 | 07:00:09 | 14 Dec 2020 | | Trixeo Aerosphere approved in the EU for COPD | RNS |
| 14/12/20 | 07:00:06 | 14 Dec 2020 | | AstraZeneca to acquire Alexion Pharmaceuticals Inc | RNS |
| 01/12/20 | 15:00:07 | 1 Dec 2020 | | Block listing Interim Review | RNS |
| 01/12/20 | 15:00:07 | 1 Dec 2020 | | Total Voting Rights | RNS |
| 01/12/20 | 07:00:07 | 1 Dec 2020 | | Crestor to be divested to Grünenthal in Europe | RNS |
| 30/11/20 | 07:00:09 | 30 Nov 2020 | | Forxiga approved in Japan for heart failure | RNS |
| 23/11/20 | 07:00:07 | 23 Nov 2020 | | AZD1222 vaccine effective against COVID-19 | RNS |
| 20/11/20 | 07:00:04 | 20 Nov 2020 | | Imfinzi new dosing approved in the US | RNS |
| 10/11/20 | 07:00:07 | 10 Nov 2020 | | Tezepelumab Phase III trial met primary endpoint | RNS |
| 09/11/20 | 07:00:12 | 9 Nov 2020 | | Calquence approved in the EU for CLL | RNS |
| 06/11/20 | 07:00:02 | 6 Nov 2020 | | Brilinta approved in the US in stroke | RNS |
| 05/11/20 | 07:15:01 | 5 Nov 2020 | | Lynparza approved in the EU for wider ovarian use | RNS |
| 05/11/20 | 07:10:02 | 5 Nov 2020 | | Lynparza approved in the EU for prostate cancer | RNS |
| 05/11/20 | 07:05:01 | 5 Nov 2020 | | Forxiga approved in the EU for heart failure | RNS |
| 05/11/20 | 07:00:04 | 5 Nov 2020 | | AZN: Year-to-date and Q3 2020 results | RNS |
| 02/11/20 | 15:00:07 | 2 Nov 2020 | | Total Voting Rights | RNS |
| 30/10/20 | 07:00:09 | 30 Oct 2020 | | Atacand to be divested in more than 70 countries | RNS |
| 29/10/20 | 07:00:09 | 29 Oct 2020 | | Directorate Change | RNS |
| 28/10/20 | 07:03:01 | 28 Oct 2020 | | Enhertu US Priority Review in gastric cancer | RNS |
| 28/10/20 | 07:00:04 | 28 Oct 2020 | | Forxiga CV outcomes benefit approved in China | RNS |
| 20/10/20 | 07:00:06 | 20 Oct 2020 | | Tagrisso adjuvant lung cancer US Priority Review | RNS |
| 19/10/20 | 07:00:16 | 19 Oct 2020 | | Forxiga HF receives positive CHMP opinion | RNS |
| 19/10/20 | 07:00:07 | 19 Oct 2020 | | Trixeo Aerosphere receives positive CHMP opinion | RNS |
| 12/10/20 | 07:00:07 | 12 Oct 2020 | | COVID-19 antibodies advance and get US funding | RNS |
| 02/10/20 | 07:00:03 | 2 Oct 2020 | | Farxiga granted US BTD in chronic kidney disease | RNS |
| 01/10/20 | 15:00:02 | 1 Oct 2020 | | Total Voting Rights | RNS |
| 25/09/20 | 07:00:03 | 25 Sept 2020 | | Directorate Change | RNS |
| 21/09/20 | 07:05:07 | 21 Sept 2020 | | Lynparza EU recommendation in prostate cancer | RNS |
| 21/09/20 | 07:00:07 | 21 Sept 2020 | | Lynparza EU recommendation in ovarian cancer | RNS |
| 21/09/20 | 07:00:06 | 21 Sept 2020 | | Tagrisso reduced early lung cancer brain recurrenc | RNS |
| 10/09/20 | 07:01:03 | 10 Sept 2020 | | AstraZeneca to list all US securities on Nasdaq | RNS |
| 10/09/20 | 07:00:06 | 10 Sept 2020 | | Fasenra PhIII OSTRO trial met co-primary endpoints | RNS |
| 01/09/20 | 15:00:01 | 1 Sept 2020 | | Total Voting Rights | RNS |
| 01/09/20 | 07:00:11 | 1 Sept 2020 | | Imfinzi approved in EU for small cell lung cancer | RNS |
| 01/09/20 | 07:00:10 | 1 Sept 2020 | | Farxiga reduces CKD progression and risk of death | RNS |
| 25/08/20 | 07:00:05 | 25 Aug 2020 | | Ph I trial begins for COVID-19 monoclonal antibody | RNS |
| 21/08/20 | 07:00:03 | 21 Aug 2020 | | Imfinzi approved in Japan for SCLC | RNS |
| 18/08/20 | 07:00:05 | 18 Aug 2020 | | Imfinzi US Priority Review; four-week, fixed dose | RNS |
| 04/08/20 | 07:00:05 | 4 Aug 2020 | | AstraZeneca prices a $3bn bond issue | RNS |
| 03/08/20 | 15:00:01 | 3 Aug 2020 | | Total Voting Rights | RNS |
| 30/07/20 | 07:25:10 | 30 Jul 2020 | | Tagrisso US BTD for EGFRm adjuvant lung cancer | RNS |
| 30/07/20 | 07:18:18 | 30 Jul 2020 | | AZN: H1 2020 results | RNS |
| 29/07/20 | 07:00:10 | 29 Jul 2020 | | Board Committee Changes | RNS |
| 28/07/20 | 07:00:04 | 28 Jul 2020 | | Farxiga DAPA-CKD trial met all endpoints | RNS |
| 27/07/20 | 07:10:06 | 27 Jul 2020 | | Calquence receives positive CHMP opinion for CLL | RNS |
| 27/07/20 | 07:05:05 | 27 Jul 2020 | | Imfinzi recommended for EU approval in SCLC | RNS |
| 27/07/20 | 07:00:09 | 27 Jul 2020 | | AstraZeneca enters collaboration in oncology | RNS |
| 24/07/20 | 07:00:03 | 24 Jul 2020 | | Breztri Aerosphere approved in the US for COPD | RNS |
| 22/07/20 | 15:00:06 | 22 Jul 2020 | | Holding(s) in Company | RNS |
| 22/07/20 | 15:00:06 | 22 Jul 2020 | | Holding(s) in Company | RNS |
